ZNF146/OZF and ZNF507 target LINE-1 sequences

Kevin M. Creamer(University of Massachusetts Chan Medical School), Jeanne B. Lawrence(University of Massachusetts Chan Medical School), Eric Larsen(University of Massachusetts Chan Medical School)
bioRxiv (Cold Spring Harbor Laboratory)
May 24, 2021
10.1101/2021.05.24.445350
Cited by 0

Related Papers

Targetable Kinase-Activating Lesions in Ph-like Acute Lymphoblastic Leukemia
|New England Journal of Medicine|2014|1.4k
PADGEM protein: A receptor that mediates the interaction of activated platelets with neutrophils and monocytes
|Cell|1989|877
Genetic Alterations Activating Kinase and Cytokine Receptor Signaling in High-Risk Acute Lymphoblastic Leukemia
|Cancer Cell|2012|722
Assessment of dexrazoxane as a cardioprotectant in doxorubicin-treated children with high-risk acute lymphoblastic leukaemia: long-term follow-up of a prospective, randomised, multicentre trial
|The Lancet Oncology|2010|452
Dexamethasone and High-Dose Methotrexate Improve Outcome for Children and Young Adults With High-Risk B-Acute Lymphoblastic Leukemia: A Report From Children’s Oncology Group Study AALL0232
|Journal of Clinical Oncology|2016|384